Stockreport

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital [Yahoo! Finance]

Alzamend Neuro, Inc.  (ALZN) 
PDF conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in healthy subjects ATLANTA Nov. 19, 2025 /PRNewswire/ -- Alzamend Neuro, Inc. (N [Read more]